<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B45B1016-314C-4E6E-9977-AF23B544953B"><gtr:id>B45B1016-314C-4E6E-9977-AF23B544953B</gtr:id><gtr:name>Tokyo Medical and Dental University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/64300AF7-F2A5-4EEC-983A-CC4168C9C664"><gtr:id>64300AF7-F2A5-4EEC-983A-CC4168C9C664</gtr:id><gtr:name>Virginia Commonwealth University</gtr:name><gtr:address><gtr:line1>Virginia Commonwealth University</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3"><gtr:id>5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3</gtr:id><gtr:name>Royal Netherlands Academy of Arts and Sciences (KNAW)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6BEBB251-2466-423A-BBB1-7B3C385CAE87"><gtr:id>6BEBB251-2466-423A-BBB1-7B3C385CAE87</gtr:id><gtr:name>London College (UCK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/815C5EC7-FEF6-4146-BF01-A7601535C8A3"><gtr:id>815C5EC7-FEF6-4146-BF01-A7601535C8A3</gtr:id><gtr:name>University of Montreal</gtr:name><gtr:address><gtr:line1>3000, chemin de la Cote-Sainte-Catherine</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2AFC5CFA-103A-40EE-8058-B8A79D2095DA"><gtr:id>2AFC5CFA-103A-40EE-8058-B8A79D2095DA</gtr:id><gtr:name>MRC Human Genetics Unit</gtr:name><gtr:address><gtr:line1>Western General Hospital</gtr:line1><gtr:line2>Crewe Road</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH4 2XU</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2AFC5CFA-103A-40EE-8058-B8A79D2095DA"><gtr:id>2AFC5CFA-103A-40EE-8058-B8A79D2095DA</gtr:id><gtr:name>MRC Human Genetics Unit</gtr:name><gtr:address><gtr:line1>Western General Hospital</gtr:line1><gtr:line2>Crewe Road</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH4 2XU</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B45B1016-314C-4E6E-9977-AF23B544953B"><gtr:id>B45B1016-314C-4E6E-9977-AF23B544953B</gtr:id><gtr:name>Tokyo Medical and Dental University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64300AF7-F2A5-4EEC-983A-CC4168C9C664"><gtr:id>64300AF7-F2A5-4EEC-983A-CC4168C9C664</gtr:id><gtr:name>Virginia Commonwealth University</gtr:name><gtr:address><gtr:line1>Virginia Commonwealth University</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3"><gtr:id>5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3</gtr:id><gtr:name>Royal Netherlands Academy of Arts and Sciences (KNAW)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6BEBB251-2466-423A-BBB1-7B3C385CAE87"><gtr:id>6BEBB251-2466-423A-BBB1-7B3C385CAE87</gtr:id><gtr:name>London College (UCK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/815C5EC7-FEF6-4146-BF01-A7601535C8A3"><gtr:id>815C5EC7-FEF6-4146-BF01-A7601535C8A3</gtr:id><gtr:name>University of Montreal</gtr:name><gtr:address><gtr:line1>3000, chemin de la Cote-Sainte-Catherine</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5A0F238B-3522-4B97-BEC2-2E5429D05818"><gtr:id>5A0F238B-3522-4B97-BEC2-2E5429D05818</gtr:id><gtr:firstName>E.</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Patton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127585840"><gtr:id>36B52DCC-55BB-4543-8AA3-D47585BE0F5E</gtr:id><gtr:title>MAPK-signalling in development and disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127585840</gtr:grantReference><gtr:abstractText>Melanoma is the most deadly form of skin cancer, and incidence continues to rise rapidly each year. In the UK, 2000 people die prematurely each year from melanoma, and once melanoma has spread there are no current treatments that successfully can be used to treat the disease. One of the ways in which melanoma can develop is from moles and we have developed a mole-to-melanoma model of cancer progression based on the most frequently mutated human gene in melanoma using the vertebrate animal called zebrafish. The way cancer develops and looks in zebrafish is highly similar to human cancers, and the genetic pathways that are altered in zebrafish cancers are the same as in people. The advantage for us with this system is that we can quickly and easily explore the function of many genes in melanoma development, as well as environmental factors that may contribute to disease. We can also test thousands of new and known chemicals in the zebrafish system that may be relevant to melanoma growth and movement in the body. Finally, the same genes that promote melanoma can also cause a syndrome called cardio-facial-cutaneous (CFC) syndrome, and we are developing new ways to look how the knowledge we gain from our melanoma studies may in fact be directly relevant to how we approach treatment for CFC.</gtr:abstractText><gtr:technicalSummary>Melanoma is the most deadly form of skin cancer, resulting in the premature death of almost 2000 people each year in the UK alone. Early detection is essential, as melanoma is notorious for being resistant to most therapies. One of the ways in which melanoma can develop is from moles (nevi): highly common and benign tumours of melanocytes, prevented from becoming neoplastic by activation of senescence. Senescence is a stable state in which cells are prevented from dividing. While a normal cell reaches senescence as it ages, it is now understood to act as a protective mechanism against cancer as well. Thus, understanding the mechanism whereby cells can sense early cancer events, and then initiate senescence, is of critical importance for our understanding of melanoma - and all cancer development - and in the design of future therapies. Our work has two main themes, MAPK-signalling in cancer and development: CANCER We have developed a mole-to-melanoma zebrafish model of cancer progression based on the most frequently mutated human gene in melanoma, BRAF. Significantly, with the loss of p53, a major regulator of senescence, melanoma rapidly develops. Because of the highly similar genetic and cancer pathology between humans and fish, we view the BRAF expressing fish as the primed human condition - a unique starting point for identifying novel genes, environmental conditions, and therapeutic compounds that control senescence and the mole-to-melanoma transition. Our aims are to: define and genetically test the role of senescence in melanoma progression; explore the gene-environment interface of UV-induced melanoma progression; test for the genetic role of new melanoma driver mutations in promoting and maintaining melanoma; screen small-molecule libraries to identify molecules that disrupt melanocyte development, movement and pigmentation, and directly test these in our animal models of melanoma. DEVELOPMENT Recently, the perception of the RAS-BRAF-MEK-ERK signalling pathway genes as cancer-genes has been dramatically altered by the discovery that, in people, germ-line mutations in RAS cause Costello syndrome, and mutations in BRAF and MEK are the cause of cardio-facial-cutaneous (CFC) syndrome. We are using the zebrafish system to understand the normal developmental function of BRAF, MEK1 and MEK2; the phenotypes imposed by CFC BRAF and MEK alleles; and to test the effects of chemical inhibitors on the activity of the CFC alleles. In this way, we strive to gain insight into how BRAF signalling contributes to the complex three-dimensional development of the embryo. Importantly, our early data suggests that small-molecule inhibitors designed to treat cancer development, can also restore normal development in CFC-model embryos. CFC in people is a progressive disease, and this works allows us to explore a new avenue using known cancer drugs to aid developmental syndromes.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1073817</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bath</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biology and Biochemistry</gtr:department><gtr:description>RK/Small molecules</gtr:description><gtr:id>480EB33D-116C-4DC9-AB6E-9245CEB5612B</gtr:id><gtr:impact>Manuscript in review (Pigment Cell and Melanoma Research)</gtr:impact><gtr:outcomeId>rmMw6KmmWeS-1</gtr:outcomeId><gtr:partnerContribution>We did a small molecule screen together, and have that paper in review. It was an excellent opportunity to learn from Robert Kelsh how to Screen zebrafish pigment cells. This was done with an Medical Research Scotland Grant.</gtr:partnerContribution><gtr:piContribution>We did the screen together at the MRC HGU, and then optimized hit compounds in our own labs. We have written a paper that is currently in review.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>CBEF7F45-3EAC-40C3-BB8C-6663194FAAB1</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-1</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Genetics &amp; Molecular Medicine</gtr:department><gtr:description>ALDH in melanoma</gtr:description><gtr:id>812EB5B2-4132-4D11-A1F2-6AD03D3B30B9</gtr:id><gtr:impact>Just started - it involved, chemistry, genetics, cell biology and cancer biology</gtr:impact><gtr:outcomeId>Qhhqm37ykuE-2</gtr:outcomeId><gtr:partnerContribution>We have just begun, but will generate new compounds and test them in the melanoma cancer stem cells of primary human cancers</gtr:partnerContribution><gtr:piContribution>We have an MRC Translation studentship to study ALDH in melanoma cancer stem cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Montreal</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>MT Drop out screen</gtr:description><gtr:id>70964910-9FFE-4BC6-A09D-C44E6DB02989</gtr:id><gtr:impact>This is a new collaboration and we do not have outputs at this stage.</gtr:impact><gtr:outcomeId>56d957d8d96974.89366030-1</gtr:outcomeId><gtr:partnerContribution>This is a new collaboration - we will be sending our MRC postdoc to Montreal to learn how to do the technique, and hopefully bring some of the technology back to the UK.</gtr:partnerContribution><gtr:piContribution>This is a new collaboration to do a gene-drug screen (drop out screen) to determine drug mechanism of action.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Virginia Commonwealth University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Biology</gtr:department><gtr:description>JL/MITF</gtr:description><gtr:id>131AE348-EEE2-4E89-AA3C-A0F7D17B02FA</gtr:id><gtr:impact>Two manuscripts: Manuscript in preparation and below


Differentiated melanocyte cell division occurs in vivo and is promoted by mutations in Mitf.
Taylor KL, Lister JA, Zeng Z, Ishizaki H, Anderson C, Kelsh RN, Jackson IJ, Patton EE.
Development. 2011 Aug;138(16):3579-89. Epub 2011 Jul 19.</gtr:impact><gtr:outcomeId>WnrpkLQoYBT-1</gtr:outcomeId><gtr:partnerContribution>We have been fortunate to receive genetic lines, and are currently writing a paper together on zebrafish melanoma.</gtr:partnerContribution><gtr:piContribution>We have been provided with genetic lines, and we are looking at the role of MITF in melanoma development, maintenance and histology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of St Andrews</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry St Andrews</gtr:department><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>B1640A48-6EE2-4223-AFEC-CE8BA0670CA0</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-2</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AUB/Chemical Biology</gtr:description><gtr:id>AA56C8DD-C611-4C2A-A539-9BC6A95C6D50</gtr:id><gtr:impact>The collaboration is multi-disciplinary - chemistry and biology.</gtr:impact><gtr:outcomeId>5448b73b428ed3.11149092-1</gtr:outcomeId><gtr:partnerContribution>My partner is a chemist, and helps train the chemistry student and together we think of new and innovative ideas about how to do chemical biology in zebrafish.</gtr:partnerContribution><gtr:piContribution>We have a shared student in chemistry and genetics. The student is part of my team, and is addressing the function of 5-nitrofurans in vivo.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of St Andrews</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry St Andrews</gtr:department><gtr:description>Chemical biology/NW</gtr:description><gtr:id>300C20E6-0934-4A15-A521-ACF4F23778C5</gtr:id><gtr:impact>Manuscript under review</gtr:impact><gtr:outcomeId>e3iQUWujVqA-1</gtr:outcomeId><gtr:partnerContribution>We have submitted a publication on small molecule target ID.</gtr:partnerContribution><gtr:piContribution>We did a small molecule screen and with a student from their lab identified the target. It has important clinical implications in the treatment of trypanosome disease. We are exploring if it is relevant to melanoma.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Human genetic disease of the MAPK pathway</gtr:description><gtr:id>DBE8B412-E34F-4F74-AB3A-0717794623E0</gtr:id><gtr:impact>Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors. Anastasaki C, Estep AL, Marais R, Rauen KA, Patton EE. Hum Mol Genet. 2009 Jul 15;18(14):2543-54. Epub 2009 Apr 17. PMID: 19376813 [PubMed - indexed for MEDLINE]


Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.
Rauen KA, Schoyer L, McCormick F, Lin AE, Allanson JE, Stevenson DA, Gripp KW, Neri G, Carey JC, Legius E, Tartaglia M, Schubbert S, Roberts AE, Gelb BD, Shannon K, Gutmann DH, McMahon M, Guerra C, Fagin JA, Yu B, Aoki Y, Neel BG, Balmain A, Drake RR, Nolan GP, Zenker M, Bollag G, Sebolt-Leopold J, Gibbs JB, Silva AJ, Patton EE, Viskochil DH, Kieran MW, Korf BR, Hagerman RJ, Packer RJ, Melese T.
Am J Med Genet A. 2010 Jan;152A(1):4-24.</gtr:impact><gtr:outcomeId>8609707C649-1</gtr:outcomeId><gtr:partnerContribution>Sharing of reagents, grant writing and publishing</gtr:partnerContribution><gtr:piContribution>Sharing of data, and ideas on human disease. We wrote a grant that was successfully funded, and have published in an medium impact journal.

We are currently exploring the effects of small molecules on behaviour.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>DDC3B50E-B41F-4049-939E-C535C3764C91</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-6</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CG MITF</gtr:description><gtr:id>3F06C770-1D76-4813-8CCB-2DB0A8C80A8E</gtr:id><gtr:impact>We are submitting a paper to a high impact journal.</gtr:impact><gtr:outcomeId>56d9a5d5f0e177.40054907-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators have identified a new pathway for MITF regulation in melanoma.</gtr:partnerContribution><gtr:piContribution>We have used zebrafish to test new MITF mutations based on work of our collaborator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Melanoma Genomes</gtr:description><gtr:id>E020066A-1F4E-4A72-96B3-B8827C91999D</gtr:id><gtr:impact>The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models.

Yen J, White RM, Wedge DC, Van Loo P, de Ridder J, Capper A, Richardson J, Jones D, Raine K, Watson IR, Wu CJ, Cheng J, Martincorena I, Nik-Zainal S, Mudie L, Moreau Y, Marshall J, Ramakrishna M, Tarpey P, Shlien A, Whitmore I, Gamble S, Latimer C, Langdon E, Kaufman C, Dovey M, Taylor A, Menzies A, McLaren S, O Meara S, Butler A, Teague J, Lister J, Chin L, Campbell P, Adams DJ, Zon LI, Patton EE, Stemple DL, Futreal PA.

Genome Biol. 2013 Oct 23;14(10):R113.</gtr:impact><gtr:outcomeId>WyRYgdqMFRo-1</gtr:outcomeId><gtr:partnerContribution>They sequenced the exomes.</gtr:partnerContribution><gtr:piContribution>We were part of a large sequencing effort of melanoma genomes in zebrafish.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Genetics Unit</gtr:department><gtr:description>NH/WT1</gtr:description><gtr:id>278FBDF5-B751-4922-9E13-8306C9767024</gtr:id><gtr:impact>We plan to submit a high impact paper.</gtr:impact><gtr:outcomeId>56d9a65bd80340.30216495-1</gtr:outcomeId><gtr:partnerContribution>Close collaboration on the discovery of a novel pathway that repairs notochord wounds.</gtr:partnerContribution><gtr:piContribution>Close collaboration on the discovery of a novel pathway that repairs notochord wounds.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Genetics &amp; Molecular Medicine</gtr:department><gtr:description>DP Anxiety</gtr:description><gtr:id>76BD077B-9334-4340-BDC0-1EF01AFDFA9C</gtr:id><gtr:impact>MEK Inhibitors Reverse cAMP-Mediated Anxiety in Zebrafish.

Lundegaard PR, Anastasaki C, Grant NJ, Sillito RR, Zich J, Zeng Z, Paranthaman K, Larsen AP, Armstrong JD, Porteous DJ, Patton EE.

Chem Biol. 2015 Oct 22;22(10):1335-46. doi: 10.1016/j.chembiol.2015.08.010. Epub 2015 Sep 17.</gtr:impact><gtr:outcomeId>56d9590f61c1c3.52389112-1</gtr:outcomeId><gtr:partnerContribution>They provided some reagents and paid for 1 year of a Masters student.</gtr:partnerContribution><gtr:piContribution>We identified a new application for cancer drugs, called MEK inhibitors to treat anxiety. We did this in an animal model (zebrafish) and identified the mechanism that drives anxiety.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London College (UCK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>VK Mosaic syndromes</gtr:description><gtr:id>CEB27C2C-A463-4EC5-A782-02EEFAAF53C9</gtr:id><gtr:impact>Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.

Thomas AC, Zeng Z, Rivi&amp;egrave;re JB, O'Shaughnessy R, Al-Olabi L, St-Onge J, Atherton DJ, Aubert H, Bagazgoitia L, Barbarot S, Bourrat E, Chiaverini C, Chong WK, Duffourd Y, Glover M, Groesser L, Hadj-Rabia S, Hamm H, Happle R, Mushtaq I, Lacour JP, Waelchli R, Wobser M, Vabres P, Patton EE, Kinsler VA.</gtr:impact><gtr:outcomeId>56d958784b4465.41829135-1</gtr:outcomeId><gtr:partnerContribution>They identified new disease genes in children that cause giant congenital nevi.</gtr:partnerContribution><gtr:piContribution>We developed a zebrafish model to validate a new disease gene found in children with giant congenital nevi.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Cell Biology</gtr:department><gtr:description>MT/Small molecule screening</gtr:description><gtr:id>306E345B-11FA-4D1B-8AD0-E24C3A8DC25A</gtr:id><gtr:impact>Three manuscripts (one in review; two published, below)



Differentiated melanocyte cell division occurs in vivo and is promoted by mutations in Mitf.
Taylor KL, Lister JA, Zeng Z, Ishizaki H, Anderson C, Kelsh RN, Jackson IJ, Patton EE.
Development. 2011 Aug;138(16):3579-89. Epub 2011 Jul 19.

Combined zebrafish-yeast chemical-genetic screens reveal gene-copper-nutrition interactions that modulate melanocyte pigmentation.
Ishizaki H, Spitzer M, Wildenhain J, Anastasaki C, Zeng Z, Dolma S, Shaw M, Madsen E, Gitlin J, Marais R, Tyers M, Patton EE.
Dis Model Mech. 2010 Sep-Oct;3(9-10):639-51. Epub 2010 Aug 16.</gtr:impact><gtr:outcomeId>RKRmZJwTnr6-1</gtr:outcomeId><gtr:partnerContribution>Publications (please see list attached)</gtr:partnerContribution><gtr:piContribution>Mike Tyers: Small molecules of interest that are identified in zebrafish are screened in yeast to identify target pathways.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bath</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biology and Biochemistry</gtr:department><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>542F6356-C83A-4486-9C6D-BBBF3597A2F0</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-3</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Netherlands Academy of Arts and Sciences (KNAW)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Hubrecht Institute</gtr:department><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>E0DAAF85-25D5-45DD-9335-3A69442F9E26</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-4</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Virginia Commonwealth University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Human and Molecular Genetics</gtr:department><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>24875032-FA03-486E-BE74-BE8ECF75AFDC</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-5</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tokyo Medical and Dental University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>Department of Stem Cell Regulation</gtr:department><gtr:description>EN/PRL3 mouse</gtr:description><gtr:id>EE1BD58D-393A-4E01-842D-EFB2FCBF8968</gtr:id><gtr:impact>We are just starting this collaboration</gtr:impact><gtr:outcomeId>idfn6hM7gwr-1</gtr:outcomeId><gtr:partnerContribution>They are the world's leading experts in melanocyte stem cells in mice.</gtr:partnerContribution><gtr:piContribution>This partner will assist us in analyzing our PRL3 mutant mice.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Conference Organization</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>34911AD2-71A4-44A4-A1E1-7FEA983EA4FC</gtr:id><gtr:impact>Over 4000 people have attended meetings that I have organized, sparking collaborations and intellectual discourse, and bringing attention to the University of Edinburgh.

? Strategic Conference for Zebrafish Investigators, Asilomar, California. January 2017 (est 150 participants)
? International Zebrafish Meeting, Florida, USA. July 2016 (estimated 800 participants)
? Zebrafish for Personalized Medicine Conference, Toronto, Canada. October 2015 (180 participants)
? European Society of Pigment Cell Research Conference, Edinburgh, September 2015 (120 participants)
? 9th European Zebrafish Meeting, Oslo, Norway. June 2015 (Scientific committee) (over 600 participants)
? The Genes &amp;amp; Cancer, Cambridge April 2015 (180 participants)
? 12th Transgenic Technology Conference and Workshop, Edinburgh, 2014. (40 people)
? The Genes &amp;amp; Cancer Meeting, Cambridge, UK. March 2014 (220 participants)
? 7th Zebrafish Disease Models Workshop Madison, USA. July 2013 (250 participants)
? International Pigment Cell Development Workshop, Edinburgh, May 2013 (50 participants)
? Genes &amp;amp; Cancer Meeting, Warwick, UK. December 2012 (150 participants)
? 5th ZDM Workshop Cold Spring Harbor Asia, Shugen, China. April 2012 (220 participants)
? The 7th European Zebrafish Meeting, Edinbugh, July 2011 (&amp;gt;750 participants)
? 4th Zebrafish Disease Models (ZDM) Workshop, Edinburgh, July 2011 (120 participants)


I started the Zebrafish Disease Models Society with currently over 280 members (www.zdmsociety.org)</gtr:impact><gtr:outcomeId>5448b954089952.72092349</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>workshop facilitator</gtr:presentationType><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9B638547-F820-4636-B3DC-32A58B441683</gtr:id><gtr:impact>BBC interview on melanoma and cancer TV and radio

Interview with journalist from Scottish newspaper

Interview for the Scotsman

Surprised by how many people in my local community told me they had seen the interview on TV. Less impact with the radio interview.

Many people commented to me in the community that they had seen the Scotsman article</gtr:impact><gtr:outcomeId>66A3164A35B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2010,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Tour to cancer research fund raisers (lay people)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>ED681732-6C99-44A5-A0D8-BF414695FC2D</gtr:id><gtr:impact>Two groups of 5 lay people who are interested in helping to raise money for cancer research. They toured the facility and we spent 1.5 hours with each group - showed melanoma models, discussed skin color and sun exposure. 

Tour of facilities and interaction day for children from a primary school in Fife.

The attendees were very grateful and sent a follow up e-mail to say how much they enjoyed it.</gtr:impact><gtr:outcomeId>opFot66f3nt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School fish tanks</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BE20F46A-C7AE-45F3-8396-A86F4F414CA2</gtr:id><gtr:impact>I have been working with a primary class of P4 / P5 - we have established fish tanks, and done breeding and genetic inheritance. This is in the town of Dunfermline, at a small local school.

We have been having fun.</gtr:impact><gtr:outcomeId>moQVmKVmQb4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lab visits</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F65547D2-B2C9-459F-A8AF-7C2D9A95FFF6</gtr:id><gtr:impact>We have had a number of visitors, from cancer research fundraising volunteers, to students from schools. My student was also interviewed by BBC Scotland. In addition we have hosted primary school students from Fife, who were amazed by the experience.

NA</gtr:impact><gtr:outcomeId>egYkFsuTQBy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E797A23E-2E53-457B-BF63-58058E5E8127</gtr:id><gtr:impact>Lecture at the Edinburgh science festival -- on cancer and zebrafish approaches to understanding disease and development, and why model organisms and basic science are so importnant

Many one-to-one discussions with audience members</gtr:impact><gtr:outcomeId>33BC8FD74D7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 Framework</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>7B90FB6B-34B7-41F3-8D1D-4710A6382A92</gtr:id><gtr:outcomeId>5C3B107B75A0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR funding (Gene-environment interactions in cancer)</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:id>F6F40D10-D4CA-4FA3-8DC2-A2839B0E2848</gtr:id><gtr:outcomeId>E7D02AB1D3E0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Scotland funding</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Scotland</gtr:fundingOrg><gtr:id>5193FCD1-248A-4863-818B-FAE88467D96C</gtr:id><gtr:outcomeId>98BDC7474320</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>222258</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (A Critical Requirement for MAPK-signaling in Development and Disease)</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A9347C84-CF68-4118-99BA-A038106DBF1D</gtr:id><gtr:outcomeId>E9950A835240</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Technology IGMM studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>99C42C78-2C75-4406-9A45-C4CE910D6BBD</gtr:id><gtr:outcomeId>WbPwxGzyGJH</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed an assay to test the activity of cardio-facio-cutaneous alleles, and to test the effects of specific clinically active drugs on restoring their &amp;quot;normal&amp;quot; activity</gtr:description><gtr:id>33D16E29-6190-4D9D-BA14-BA73D9CDDE37</gtr:id><gtr:impact>Publication -- Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors. Anastasaki C, Estep AL, Marais R, Rauen KA, Patton EE. Hum Mol Genet. 2009 Jul 15;18(14):2543-54. Epub 2009 Apr 17. PMID: 19376813 [PubMed - indexed for MEDLINE]

Anastasaki C, Rauen KA, Patton EE. Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish. Dis Model Mech. 2012 Jul;5(4):546-52.</gtr:impact><gtr:outcomeId>31DAE82C6BA</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CFC-zebrafish</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19376813</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have made a series of transgenic lines expressing melanoma cancer genes.</gtr:description><gtr:id>3ACD68E1-6C59-4987-B1C6-3CF5FC0B4E7D</gtr:id><gtr:impact>We are currently using these in manuscripts and then will be provided to other research groups.</gtr:impact><gtr:outcomeId>PGUU5UeEvmm</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>transgenic lines</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>PRL3 mouse mutant</gtr:description><gtr:id>E44B5BBD-0924-4943-AEE6-08E14811D528</gtr:id><gtr:impact>This is the first mammalian model for loss of PRL3 function. We know that PRL3 is important in melanoma, and we aim to test this question, as well as it's role in melanocyte stem cells.</gtr:impact><gtr:outcomeId>QT7S3kF91JX</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PRL3 (mouse)</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed an important mutant line for our research in a gene called PRL3 in zebrafish</gtr:description><gtr:id>33088C0E-0185-49D7-91BC-C38AB8CA091B</gtr:id><gtr:impact>This will be critical to understand the role of PRL3 in an animal system, especially in melanocyte regeneration. It is currently unpublished.</gtr:impact><gtr:outcomeId>MUhncYPrccj</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PRL3 mutant</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>a small molecule that causes a specific developmental phenotype (kills developing and differentiated melanocytes)</gtr:description><gtr:id>D13B7F50-F11E-4BA8-9F83-6BA553BF4E7C</gtr:id><gtr:impact>n/a considering for patent</gtr:impact><gtr:outcomeId>C747AA31E73</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Small molecule</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8597B177-17EA-44F6-8FA9-F3017445809A</gtr:id><gtr:title>Knockdown of the zebrafish ortholog of the retinitis pigmentosa 2 (RP2) gene results in retinal degeneration.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db00806632c3ff9c2dee3e5d6f9804c"><gtr:id>9db00806632c3ff9c2dee3e5d6f9804c</gtr:id><gtr:otherNames>Shu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>mHS3aWaH6ZA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24A59DB8-0E5D-42DE-B866-BE1DD1BFE160</gtr:id><gtr:title>Small molecule screening identifies targetable zebrafish pigmentation pathways.</gtr:title><gtr:parentPublicationTitle>Pigment cell &amp; melanoma research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92954cdda9688e660ad9cecc318fa2d4"><gtr:id>92954cdda9688e660ad9cecc318fa2d4</gtr:id><gtr:otherNames>Colanesi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1755-1471</gtr:issn><gtr:outcomeId>pm_15255_25_22252091</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E7451FA-5487-4EB8-B9D6-EBD67410DD7A</gtr:id><gtr:title>Differentiated melanocyte cell division occurs in vivo and is promoted by mutations in Mitf.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94aaade2e9d35ffb15c39ffc30f2e535"><gtr:id>94aaade2e9d35ffb15c39ffc30f2e535</gtr:id><gtr:otherNames>Taylor KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>V8RSitnkW68</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D693EB3F-7EFC-4FF5-8758-6E2939FC8041</gtr:id><gtr:title>Generating and analyzing fish models of melanoma.</gtr:title><gtr:parentPublicationTitle>Methods in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0091-679X</gtr:issn><gtr:outcomeId>RGNYBBnE81u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6062866E-9A62-4759-9F34-41BC910BF3F9</gtr:id><gtr:title>The melanocyte lineage in development and disease.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027f74ba079c0fe824ee3db32de2d602"><gtr:id>027f74ba079c0fe824ee3db32de2d602</gtr:id><gtr:otherNames>Mort RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>56d962ca463f31.32389872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>223ED1B5-F547-49A8-8342-79CFF3F570E1</gtr:id><gtr:title>Temperature-sensitive splicing of mitfa by an intron mutation in zebrafish.</gtr:title><gtr:parentPublicationTitle>Pigment cell &amp; melanoma research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a111a9043650e30f5eae331d4f2c9b"><gtr:id>02a111a9043650e30f5eae331d4f2c9b</gtr:id><gtr:otherNames>Zeng Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1755-1471</gtr:issn><gtr:outcomeId>56d9636be10662.73366690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4203418B-3B87-4C66-86BB-12AA28917B57</gtr:id><gtr:title>Genetic models of cancer in zebrafish.</gtr:title><gtr:parentPublicationTitle>International review of cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d88d5a5e82037013765ad0dc4476bc0"><gtr:id>4d88d5a5e82037013765ad0dc4476bc0</gtr:id><gtr:otherNames>Amatruda JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1937-6448</gtr:issn><gtr:outcomeId>3DAA981F421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38A5EA8C-834B-43C1-9C25-90FB3354670E</gtr:id><gtr:title>Rapid synthesis and zebrafish evaluation of a phenanthridine-based small molecule library.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99a8882f855d8758ccdbe32b185e6504"><gtr:id>99a8882f855d8758ccdbe32b185e6504</gtr:id><gtr:otherNames>Donaldson LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>qcGPT96bNYp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52A0B1AF-AB2C-4B18-B3B5-743B5D8FE8A0</gtr:id><gtr:title>Cross-species models of human melanoma.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf9a4b415a8696967a5bf0e850388395"><gtr:id>bf9a4b415a8696967a5bf0e850388395</gtr:id><gtr:otherNames>van der Weyden L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>56d9643319ac69.12108252</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5988CBE8-2E9F-4B19-9D78-8FC132BBCAFE</gtr:id><gtr:title>ALDH2 mediates 5-nitrofuran activity in multiple species.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/240a27c7bd5d10365eaae398f59768ee"><gtr:id>240a27c7bd5d10365eaae398f59768ee</gtr:id><gtr:otherNames>Zhou L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>pm_15255_25_22840776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>639A6C7A-30EB-47FC-8CB8-DB5637490F51</gtr:id><gtr:title>Zebrafish have a competent p53-dependent nucleotide excision repair pathway to resolve ultraviolet B-induced DNA damage in the skin.</gtr:title><gtr:parentPublicationTitle>Zebrafish</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a111a9043650e30f5eae331d4f2c9b"><gtr:id>02a111a9043650e30f5eae331d4f2c9b</gtr:id><gtr:otherNames>Zeng Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1545-8547</gtr:issn><gtr:outcomeId>P7ELdhgWuZZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD6B2CBC-4D62-4461-8A5C-D52F2985CF5B</gtr:id><gtr:title>Topoisomerase II alpha is required for embryonic development and liver regeneration in zebrafish.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5cd49be9c05c60384c2408e85ff42bf"><gtr:id>b5cd49be9c05c60384c2408e85ff42bf</gtr:id><gtr:otherNames>Dovey M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>C13725CB8BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3D18F72-F5AE-43B3-B875-46E0C6DB1D9D</gtr:id><gtr:title>The INT6 cancer gene and MEK signaling pathways converge during zebrafish development.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b1356121a56c6fdc61a1549985596b4"><gtr:id>5b1356121a56c6fdc61a1549985596b4</gtr:id><gtr:otherNames>Grzmil M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>1EF9F4BD604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9904F586-3923-4246-8FE8-91F03471B042</gtr:id><gtr:title>Spotlight on zebrafish: translational impact.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>5448b64c1df328.36754399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F16C4D1C-B1E7-4449-AA2F-20518FA4E9F7</gtr:id><gtr:title>Xmrk in medaka: a new genetic melanoma model.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>oyYbmLnwJ3p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B62EF3A-02AE-431B-ABDB-224A60D872EC</gtr:id><gtr:title>Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf3c200e2cedc5955838513cef90320c"><gtr:id>bf3c200e2cedc5955838513cef90320c</gtr:id><gtr:otherNames>Al-Olabi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5a9e77488965c9.25136466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE030DDF-C787-4DF4-A035-3620436B3538</gtr:id><gtr:title>Dhx34 and Nbas function in the NMD pathway and are required for embryonic development in zebrafish.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64df654b946ab3959a8d0b1c24653e0f"><gtr:id>64df654b946ab3959a8d0b1c24653e0f</gtr:id><gtr:otherNames>Anastasaki C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>skQesppmr2d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BE6CD57-87E4-4D58-9533-F0563D0CFBAB</gtr:id><gtr:title>A zebrafish model for nevus regeneration.</gtr:title><gtr:parentPublicationTitle>Pigment cell &amp; melanoma research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c851eb2d12d3a0bb01a4451e6b33fc0"><gtr:id>8c851eb2d12d3a0bb01a4451e6b33fc0</gtr:id><gtr:otherNames>Richardson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1755-1471</gtr:issn><gtr:outcomeId>SznVsjt9y3N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DA584DC-6BE4-4E07-BC47-5D986C645644</gtr:id><gtr:title>Combined zebrafish-yeast chemical-genetic screens reveal gene-copper-nutrition interactions that modulate melanocyte pigmentation.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ce8ef93758161a5b7ae3821c83ced0d"><gtr:id>6ce8ef93758161a5b7ae3821c83ced0d</gtr:id><gtr:otherNames>Ishizaki H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>cdhNHK2GaE3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C8C2706-81DE-4ED9-813B-66DBF9D3DECB</gtr:id><gtr:title>A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9adcead17be9031b569c1cdc871187a1"><gtr:id>9adcead17be9031b569c1cdc871187a1</gtr:id><gtr:otherNames>Lister JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15255_25_23831555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F905C6A3-54E8-4AEF-90C4-F6F80C6E9184</gtr:id><gtr:title>DHX34 and NBAS form part of an autoregulatory NMD circuit that regulates endogenous RNA targets in human cells, zebrafish and Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fe57c499043fa731755dcdc48d96ebe"><gtr:id>3fe57c499043fa731755dcdc48d96ebe</gtr:id><gtr:otherNames>Longman D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_15255_25_23828042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6BD700A-538A-4AE4-BFCB-087BF2A9F957</gtr:id><gtr:title>Going forward together: cooperative invasion in melanoma.</gtr:title><gtr:parentPublicationTitle>Pigment cell &amp; melanoma research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/867f81c03e03325e2cac43d157d81125"><gtr:id>867f81c03e03325e2cac43d157d81125</gtr:id><gtr:otherNames>Wojciechowska S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1755-1471</gtr:issn><gtr:outcomeId>5448b64ba59fb2.67269869</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B3C0657-3A88-4509-B85B-560BFF560860</gtr:id><gtr:title>Live imaging in zebrafish reveals neu(trophil) insight into the metastatic niche.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>pm_15255_25_22611003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E993CF4-0D1D-4140-AABD-9BA44C61D3D2</gtr:id><gtr:title>Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bfae243ebd3e87411202acf1063603e"><gtr:id>3bfae243ebd3e87411202acf1063603e</gtr:id><gtr:otherNames>Weiss JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5448b64c813627.94750292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF9C457C-1650-4DE4-863E-E0C5B6B0DEA0</gtr:id><gtr:title>Cancer: Trouble upstream.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15255_25_23518559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1170A5D-357E-4BEA-B13E-9C01A47D74A3</gtr:id><gtr:title>Genetic and environmental melanoma models in fish.</gtr:title><gtr:parentPublicationTitle>Pigment cell &amp; melanoma research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1755-1471</gtr:issn><gtr:outcomeId>HLmLcfUt4kJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17C4D70C-5BD5-4E47-AB94-33E99390BB2D</gtr:id><gtr:title>Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64df654b946ab3959a8d0b1c24653e0f"><gtr:id>64df654b946ab3959a8d0b1c24653e0f</gtr:id><gtr:otherNames>Anastasaki C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>C2EAED620DB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>982C9175-A872-43A6-A038-19331134D2CF</gtr:id><gtr:title>Assessment of biocompatibility of 3D printed photopolymers using zebrafish embryo toxicity assays.</gtr:title><gtr:parentPublicationTitle>Lab on a chip</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba85725b08f770467701034537d5754a"><gtr:id>ba85725b08f770467701034537d5754a</gtr:id><gtr:otherNames>Macdonald NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-0189</gtr:issn><gtr:outcomeId>56d96586b55191.19630958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DB4BDCB-CB7D-4DEC-B458-DA60265DC5C9</gtr:id><gtr:title>Sharing chemical libraries within the European zebrafish community.</gtr:title><gtr:parentPublicationTitle>Zebrafish</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44d29c2750f7729ddffc3adb37267cca"><gtr:id>44d29c2750f7729ddffc3adb37267cca</gtr:id><gtr:otherNames>Grabher C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1545-8547</gtr:issn><gtr:outcomeId>RDTftXyZGwg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5489FD62-B62E-4341-88AA-BB8AF1EF512C</gtr:id><gtr:title>N-alkynyl derivatives of 5-fluorouracil: susceptibility to palladium-mediated dealkylation and toxigenicity in cancer cell culture.</gtr:title><gtr:parentPublicationTitle>Frontiers in chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bfae243ebd3e87411202acf1063603e"><gtr:id>3bfae243ebd3e87411202acf1063603e</gtr:id><gtr:otherNames>Weiss JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2296-2646</gtr:issn><gtr:outcomeId>5448b64bdc5f59.42169775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D9C3DAC-3393-4F12-8F63-BE0A0405AC05</gtr:id><gtr:title>MEK Inhibitors Reverse cAMP-Mediated Anxiety in Zebrafish.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1a14c14a4cec869f0b40087202f1995"><gtr:id>d1a14c14a4cec869f0b40087202f1995</gtr:id><gtr:otherNames>Lundegaard PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>56d963ce660df0.99267370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63C3C28A-C1EA-46C0-A9D2-68D1AF81BE41</gtr:id><gtr:title>Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64df654b946ab3959a8d0b1c24653e0f"><gtr:id>64df654b946ab3959a8d0b1c24653e0f</gtr:id><gtr:otherNames>Anastasaki C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_15255_25_22301711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EE65F82-69E2-466F-AF13-F6BDE05DAC60</gtr:id><gtr:title>Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads.</gtr:title><gtr:parentPublicationTitle>Cell communication and signaling : CCS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94aaade2e9d35ffb15c39ffc30f2e535"><gtr:id>94aaade2e9d35ffb15c39ffc30f2e535</gtr:id><gtr:otherNames>Taylor KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1478-811X</gtr:issn><gtr:outcomeId>CudNRDYZ19q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6865EBF-AEA3-4654-AD0D-3453EDFFA217</gtr:id><gtr:title>Dopamine from the brain promotes spinal motor neuron generation during development and adult regeneration.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/933b6a4c26bb49ddb19fbe1a2676cc53"><gtr:id>933b6a4c26bb49ddb19fbe1a2676cc53</gtr:id><gtr:otherNames>Reimer MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>pm_15255_25_23707737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67954899-DA64-4216-9811-7DD2DF68AACD</gtr:id><gtr:title>Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bfae243ebd3e87411202acf1063603e"><gtr:id>3bfae243ebd3e87411202acf1063603e</gtr:id><gtr:otherNames>Weiss JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>5448b64c4f2bc0.48517926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A1A7FBC-E89B-46C0-8996-CD997DA8D7F1</gtr:id><gtr:title>Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f96aa26dd4824844aa3b47638e9597c"><gtr:id>7f96aa26dd4824844aa3b47638e9597c</gtr:id><gtr:otherNames>Rauen KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>YutKcBoukmv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33697FA4-EC99-4996-BD0D-40C2FB6EA044</gtr:id><gtr:title>mc1r Pathway regulation of zebrafish melanosome dispersion.</gtr:title><gtr:parentPublicationTitle>Zebrafish</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c851eb2d12d3a0bb01a4451e6b33fc0"><gtr:id>8c851eb2d12d3a0bb01a4451e6b33fc0</gtr:id><gtr:otherNames>Richardson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1545-8547</gtr:issn><gtr:outcomeId>AEDD9654121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC2779BF-7BFC-4BB8-BEFD-62A66BE48C19</gtr:id><gtr:title>The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ce84cab72cc356c1d67cb37a3ccc8f9"><gtr:id>1ce84cab72cc356c1d67cb37a3ccc8f9</gtr:id><gtr:otherNames>Yen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_15255_25_24148783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B503F31A-A149-4C39-92F2-405913798048</gtr:id><gtr:title>Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7dda45248e47eb0023a4ccbd6908c4e"><gtr:id>a7dda45248e47eb0023a4ccbd6908c4e</gtr:id><gtr:otherNames>Thomas AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>56d966d0474e29.97964444</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E01DF3D-D235-449A-8FD2-925B0032581A</gtr:id><gtr:title>Zebrafish Rpgr is required for normal retinal development and plays a role in dynein-based retrograde transport processes.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db00806632c3ff9c2dee3e5d6f9804c"><gtr:id>9db00806632c3ff9c2dee3e5d6f9804c</gtr:id><gtr:otherNames>Shu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>BFB6109A6AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2D5BDC1-13D8-41B4-ABA6-269FA65EADDB</gtr:id><gtr:title>The melanocyte lineage in development and disease.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027f74ba079c0fe824ee3db32de2d602"><gtr:id>027f74ba079c0fe824ee3db32de2d602</gtr:id><gtr:otherNames>Mort RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>56d962ca087ba5.66716204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67FC7AA8-1258-4F3C-8797-61130498A1B3</gtr:id><gtr:title>A novel role for Glucocorticoid-Induced TNF Receptor Ligand (Gitrl) in early embryonic zebrafish development.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c41d2bf9a341063b77248da8e2ea40a"><gtr:id>7c41d2bf9a341063b77248da8e2ea40a</gtr:id><gtr:otherNames>Poulton LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>092847AA922</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127585840</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>7EE9741E-CF94-420A-B0AB-A7811523CF2C</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Skin</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>